N
Nanovision Technology
Nanovision Technology is a high-tech enterprise focused on high-speed and high-precision radiology
About Nanovision Technology
Established in March 2014, Nanovision Technology (Beijing) Co., Ltd. is a high-tech enterprise concentrating on high-speed and high-precision radiological imaging. The company operates from its headquarters in Beijing's Zhongguancun Yongfeng high-tech industrial base, with additional subsidiaries established in Chengdu and Shanghai. Nanovision's business model is centered on providing core components and comprehensive 2D/3D imaging solutions to manufacturers of medical and industrial imaging equipment. The firm generates revenue through the design, development, and sale of its specialized hardware and software products.
Read full description
The company was founded by Li Yunxiang and began with angel investment, subsequently securing multiple rounds of funding from investors including Legend Capital, Sherpa Venture Capital, and Tencent Investment. Nanovision has achieved significant milestones, including receiving titles such as "National High-tech Enterprise" and "Zhongguancun High-tech Enterprise". The company has built a robust intellectual property portfolio with over 100 patents and software copyrights.
Nanovision's product portfolio is focused on static CT systems, novel X-ray sources, and advanced detectors. A key offering is the world's first static CT scanner, the CompoundEye 24, which debuted with its initial clinical images at RSNA 2024. Another significant development is the 'Photon Stream' detector, a technology positioned between conventional photon integration and newer photon counting detectors, designed to achieve single-photon counting effects at high speeds. The company also developed China's first self-developed CMOS flat panel detector, the Merak series, which serves the medical, industrial, and security sectors. These products aim to provide higher precision and speed while overcoming limitations of traditional CT technology, such as the trade-offs between resolution, speed, and spectral information.
At a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Haidian, China
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 53.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Radiology, Medical Imaging, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Nanovision Technology.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCEquity / VC | Mar 2022 | $14M | $56M | Maxvision Technology | — |
| OtherOther financing | Jan 2021 | $0 | — | Proxima Ventures | ↗ |
Growth signals
Latest recorded traffic for Nanovision Technology is 50 monthly website visits, down 92.6% over the last three months. Nanovision Technology's team grew 5.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Sherpa Venture Partners
Legend Capital
Maxvision Technology
Other known investors2 additional known investors
Proxima Ventures
NLVC
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nanovision Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nanovision Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.